Related Experiment Video
Updated: Jan 24, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
A PUBLIC HEALTH PERSPECTIVE ON THE IMPORTANCE OF PLASMA PHENYLALANINE AND TYROSINE DETERMINATION IN RELATION TO
F Belengeanu1,2, L Moş3,4, A Covaci3
1"Vasile Goldiş" Western University of Arad, Institute of Life Sciences and Faculty of Medicine, Cluj-Napoca, Romania.
Insights
Newborn screening for phenylketonuria (PKU) requires frequent phenylalanine (Phe) monitoring. A new, simple, and accurate method for simultaneous Phe and tyrosine measurement aids early diagnosis and treatment, preventing intellectual disability.
Area of Science:
- Biochemistry
- Clinical Chemistry
- Public Health
Background:
- Newborn screening programs, including for phenylketonuria (PKU), are crucial for early detection of metabolic disorders.
- PKU management necessitates regular monitoring of phenylalanine (Phe) levels in blood plasma to prevent neurological damage.
- Existing diagnostic methods may pose challenges for widespread implementation in clinical laboratories.
Discussion:
- A novel, cost-effective procedure enables simultaneous determination of Phe and tyrosine plasma concentrations.
- This method is highly sensitive, accurate, and user-friendly, suitable for laboratories without prior experience in amino acid disorder diagnosis.
- Implementing this assay can significantly improve PKU detection rates and management outcomes.
Key Insights:
- The described method offers a simplified approach to essential PKU monitoring.
- Simultaneous Phe and Tyr measurement provides comprehensive data for patient management.
- Early and accurate diagnosis through improved screening prevents severe public health consequences like preventable mental retardation.
Outlook:
- Wider adoption of this assay in clinical laboratories can enhance newborn screening protocols globally.
- This advancement supports better management of inherited metabolic disorders, reducing long-term patient burden.
- Further research may focus on refining the assay for even broader applicability and integration into automated systems.
Abstract:
Newborn screening of phenylketonuria (PKU) is performed in many countries, including Romania, in addition to screening for congenital hypothyroidism. Patients affected by PKU require frequent measurements of phenylalanine (Phe) level in blood plasma. Such a determination is important not only in early diagnostic, but also in monitoring the treatment of PKU to maintain phenylalaninemia within limits that will not affect the brain. A simple, highly sensitive, accurate and rather inexpensive procedure for the simultaneous determination of Phe and Tyr plasma concentrations was previously described in this journal. The new procedure may be applied in many clinical laboratories, including those with no previous experience in diagnosis of inherited amino acid metabolic disorders. In this way the major public health problems linked to PKU not being detected in the first weeks of life (including the burden of institutionalized children with preventable mental retardation) may be avoided.
Related Concept Videos
Self-Presentation: Self-Monitoring and Self-Handicapping
Receptor Tyrosine Kinases
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Psychodynamic Perspectives on Personality
Psychodynamic theorists argue that unconscious...
The Behavioral Perspective on Personality
Criticisms of the Evolutionary Perspective
Evolutionary psychology provides one explanation for these findings, suggesting...

